Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | GBA1 | P04062 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MMP1 | P03956 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8851813 | 0.83 | ALDH1A1 (0.66) | ALDH1A1LMNASMN1; SMN2KEAP1KDM4E | |
| SCHEMBL21455640 | 0.81 | ALDH1A1 (0.68) | ALDH1A1LMNASMN1; SMN2KDM4EGBA1 | |
| SCHEMBL6006902 | 0.81 | ALDH1A1 (0.57) | ALDH1A1LMNASMN1; SMN2KEAP1KDM4E | |
| SCHEMBL301743 | 0.80 | ALDH1A1 (0.67) | ALDH1A1LMNASMN1; SMN2KEAP1KDM4E | |
| SCHEMBL8349568 | 0.79 | ALDH1A1 (0.79) | ALDH1A1LMNASMN1; SMN2KEAP1KDM4E | |
| SCHEMBL2372712 | 0.79 | BCAT1 (0.56) | ALDH1A1LMNASMN1; SMN2KEAP1KDM4E | |
| Hydrochloric Acid SCHEMBL7530847 | 0.78 | ALDH1A1 (0.64) | ALDH1A1LMNASMN1; SMN2KEAP1KDM4E | |
| SCHEMBL12672473 | 0.78 | ALDH1A1 (0.70) | ALDH1A1LMNASMN1; SMN2KEAP1KDM4E | |
| SCHEMBL12672466 | 0.78 | ALDH1A1 (0.70) | ALDH1A1LMNASMN1; SMN2KEAP1KDM4E | |
| SCHEMBL27276998 | 0.78 | ALDH1A1 (0.64) | ALDH1A1LMNASMN1; SMN2KEAP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100009970-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES | COMBINATORX (SINGAPORE) PTE. LTD. (SG) | 2010-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100009970-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES | HTR1A, HTR3B, HTR3A | ALDH1A1 2240/4885LMNA 692/4885SMN1; SMN2 862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.